Prominent Cutaneous Manifestation of COVID-19: A Case Report

April 2021 in “ European medical journal ”

Cristina Galván-Casas, Juan Ochoa-Bermúdez, Sara Muñoz-Ordoñez, Álvaro Tovar-Cock, Telma Meizoso

hair loss telogen effluvium alopecia areata skin rash itchy lesions painful lesions cutaneous manifestation immune response

TLDR A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

The document presents a case report of a 47-year-old female patient who experienced prominent skin manifestations as a result of COVID-19. The patient's symptoms included a skin rash, itchy and painful lesions, and later, hair loss. The skin lesions were complex, long-lasting, and highly symptomatic, representing the most striking symptom of the patient’s symptomatology. These lesions concurred with mild general symptoms in the second week after onset and lasted for 2 months. Four weeks after the disappearance of the skin lesions, the patient experienced intense telogen effluvium and alopecia areata, two types of hair loss with different physiopathology, which do not usually appear concomitantly. The authors suggest that the patient's specific and dysregulated immune response led to her diverse and prolonged dermatological manifestations. The case highlights the need for further research into the skin manifestations of COVID-19, as they can provide valuable insights into the disease.

View this study on emjreviews.com →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research Relative Changes in the Pattern of Diseases Presenting in Dermatology Outpatient Clinic in the Era of the COVID-19 Pandemic

43 citations, July 2020 in “Dermatologic Therapy”

During the COVID-19 pandemic, a clinic in Turkey saw fewer patients but more cases of certain skin conditions, possibly linked to the virus and stress.

research Dengue-Associated Telogen Effluvium: A Report of 14 Patients

13 citations, May 2017 in “Dermatologica Sinica”

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

Related Community Posts Join

6 / 1000+ results

community The Worst Hair Loss Condition You (MAY) have: LPP

in Research/Science 43 upvotes 2 months ago

Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.

community C’est terrible - at my wits end

in Female 443 upvotes 1 year ago

A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

community Diffuse hair loss and scalp biopsies

in Research 692 upvotes 3 months ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community HLT Megathread on HMI-115 (key takeaways in comments)

in Research/Science 40 upvotes 1 year ago

HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

community The Real Cause Of Androgenetic Alopecia

in Research/Science 667 upvotes 1 month ago

Androgenetic alopecia is caused by DHT affecting hair growth. Finasteride and minoxidil are used to manage hair loss by blocking DHT and promoting hair growth.

community I am a dermatologist with a clinical interest in alopecia. AMA

in Will treatment work for me? 2 years ago

In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.